EndoCross

Medical Devices for Cardiovascular Treatment

Health Tech & Life Sciences
Non Active, Oct 2017
Mature Yokne'am Illit Founded 2006
LinkedIn
Total raised
$2.5M
Last: Undisclosed 2008-11
Stage
Mature
Founded
2006
Headcount
117,290
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences

About

EndoCross develops and markets solutions to treat challenging lesions, including chronic total occlusions (CTOs). Its first product, the ENABLER-P Catheter System, is CE marked and designed for use in the peripheral vasculature, including above-the-knee and below-the-knee vessels. The company is also introducing the ENABLER-C Catheter System for use in coronary environments. The ENABLER technology can advance a guidewire in challenging environments, including crossing long and severely calcified CTOs. Using traditional balloon technologies, EndoCross has developed a balloon designed to provide guidewire support, centralization, and controlled advancement. The full ENABLER Catheter System comprises the ENABLER-P Catheter, the ENABLER Pressure Control Unit, a syringe set, and a sterile cover.

Funding history · 1 round · $2.5M total

2008-11
Undisclosed $2.5M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

cathetersmedical-deviceshospitalscardiovascularsurgeryvascularcardiology